| PHAS Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||
Below is a table of the PHAS shares outstanding history going back to 10/18/2018:
Also see: PHAS Market Cap History PHAS YTD Return |
PHAS Shares Outstanding History — PhaseBio Pharmaceuticals Share Count Over Time
As of 8/8/2022 PhaseBio Pharmaceuticals has 49.86 million PHAS shares outstanding. Investors often track the PHAS shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows PHAS share count trends over time, with 18 historical shares outstanding datapoints presented, dating back to 10/18/2018.
| PHAS Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||
PHAS Historical Shares Outstanding: +27.80% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||
| PHAS Stock Price Chart |
| About PhaseBio Pharmaceuticals Inc |
| PhaseBio Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for cardiopulmonary diseases. Co.'s primary product candidate, bentracimab, is a reversal agent for the antiplatelet drug ticagrelor. Co. is developing its preclinical product candidate, PB6440, is an aldosterone synthase inhibitor being developed for treatment-resistant hypertension. Co.'s preclinical programs include: Glucagon-like peptide-2, which stimulates growth of intestinal villi, increasing their ability to absorb nutrients and C-type natriuretic peptide, which is a regulator of bone growth and can rescue defects in fibroblast growth factor 3. We show 18 historical shares outstanding datapoints in our coverage of PHAS's shares outstanding history. Understanding the changing numbers of PHAS shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like PHAS versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching PHAS by allowing them to research PHAS shares outstanding history as well as any other stock in our coverage universe. |
| PHAS Current Stock Quote |
Quotes delayed 20 minutes  Free PHAS Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| PHAS Share Performance |
| Shares Outstanding Peers |
| PhaseBio Pharmaceuticals (PHAS) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
PHAT Shares Outstanding History PHIO Shares Outstanding History PIII Shares Outstanding History PIRS Shares Outstanding History PKI Shares Outstanding History PLRX Shares Outstanding History PLSE Shares Outstanding History PLUR Shares Outstanding History PLXP Shares Outstanding History PMCB Shares Outstanding History More Healthcare companies » |
PHAS Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
